Chemo, a global pharmaceutical company, is making significant strides in the healthcare industry. With a diverse portfolio and a dedicated team, Chemo is committed to improving health and well-being at every stage of life.
APIs & FDFs
At the heart of Chemo’s operations are its Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). These are manufactured for both human and veterinary use, spanning across major treatment areas.
Chemo boasts a portfolio of over 100 molecules and more than 50 pharmaceuticals. This includes a wide range of drugs such as steroids, antiulcer drugs, hormones, antifungals, prostaglandins, antihistamines, PPIs, respiratory drugs, antibiotics, and oral hormonal contraceptives.
The company also offers a diverse range of pharmaceutical forms with almost 200 different formulations. These include tablets, capsules, granules, inhalers, injectables, and suspensions.
Broad Treatment Areas
Chemo covers a broad range of treatment areas including cardiology, gastroenterology, central nervous system, anti-infectives, respiratory, women’s health, endocrinology, dermatology, and urology. This wide coverage allows Chemo to cater to a diverse set of healthcare needs.
Quality and safety are integral to Chemo’s operations. The company has an integrated quality and safety system in place for the product manufacturing process across all of its production centres.
Chemo complies fully with regulatory requirements, including Good Manufacturing Practices (GMP) and international guidelines and standards for the pharmaceutical industry. This includes agreements included in product licenses, marketing authorisations, documentation submitted for registration with health authorities, and requirements stipulated in internal documents created by the Corporate Quality Department.
Chemo’s commitment to quality, safety, and broad coverage of treatment areas positions it as a significant player in the global pharmaceutical industry. As the company continues to innovate and expand, it promises to be a beacon of hope for patients worldwide.
– Sasidhar Bodapati
